Cargando…
Modeling alpha-synuclein pathology in a human brain-chip to assess blood-brain barrier disruption
Parkinson’s disease and related synucleinopathies are characterized by the abnormal accumulation of alpha-synuclein aggregates, loss of dopaminergic neurons, and gliosis of the substantia nigra. Although clinical evidence and in vitro studies indicate disruption of the Blood-Brain Barrier in Parkins...
Autores principales: | Pediaditakis, Iosif, Kodella, Konstantia R., Manatakis, Dimitris V., Le, Christopher Y., Hinojosa, Chris D., Tien-Street, William, Manolakos, Elias S., Vekrellis, Kostas, Hamilton, Geraldine A., Ewart, Lorna, Rubin, Lee L., Karalis, Katia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8501050/ https://www.ncbi.nlm.nih.gov/pubmed/34625559 http://dx.doi.org/10.1038/s41467-021-26066-5 |
Ejemplares similares
-
A microengineered Brain-Chip to model neuroinflammation in humans
por: Pediaditakis, Iosif, et al.
Publicado: (2022) -
Modeling alcohol-associated liver disease in a human Liver-Chip
por: Nawroth, Janna C., et al.
Publicado: (2021) -
Assessment of α-Synuclein Secretion in Mouse and Human Brain Parenchyma
por: Emmanouilidou, Evangelia, et al.
Publicado: (2011) -
In silico modeling of the effects of alpha-synuclein oligomerization on dopaminergic neuronal homeostasis
por: Ouzounoglou, Eleftherios, et al.
Publicado: (2014) -
Duodenum Intestine-Chip for preclinical drug assessment in a human relevant model
por: Kasendra, Magdalena, et al.
Publicado: (2020)